Logo image
Mesenteric vein thrombosis in a patient heterozygous for factor V Leiden and G20210A prothrombin genotypes
Journal article   Open access

Mesenteric vein thrombosis in a patient heterozygous for factor V Leiden and G20210A prothrombin genotypes

Paras Karmacharya, Madan Raj Aryal and Anthony Donato
World journal of gastroenterology : WJG, v 19(43), pp 7813-7815
21 Nov 2013
PMID: 24282370
url
https://doi.org/10.3748/wjg.v19.i43.7813View
Published, Version of Record (VoR) Open

Abstract

Gastroenterology & Hepatology Life Sciences & Biomedicine Science & Technology
Mesenteric venous thrombosis (MVT) is a rare but life threatening form of bowel ischemia. It is implicated in 6%-9% of all cases of acute mesenteric ischemia. The proportion of patients with primary (or idiopathic) MVT varies from 0% to 49%, with a decrease in frequency secondary to more recent availability of newer investigations for hypercoagulability. The presence of factor V Leiden (FVL) and prothrombin G20210A mutations (PGM) have been well documented in these cases. However, there have been scarce case reports describing MVT in heterozygotes of both these mutations occurring simultaneously and its implications on long term management. Our case describes acute MVT in a previously asymptomatic young patient with no prior history of venous thromboembolism. The patient was found to be heterozygous for FVL and PGM and treated with lifelong anticoagulation with warfarin (goal international normalized ratio: 2-3) and avoidance of hormonal contraceptives. (C) 2013 Baishideng Publishing Group Co., Limited. All rights reserved.

Metrics

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Gastroenterology & Hepatology
Logo image